NAI500 Special Coverage: With Global CBD Legislations Solidifying, is the Industry at a Tipping Point for Investors? Cannabis, Life Science
Healthcare Roundup – FDA says COVID-19 vaccines targeting variants won’t need lengthy trials; Recreational marijuana use officially legalized in New Jersey Life Science
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva Life Science
Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23% Life Science
Healthcare Roundup – Merck and Teva in talks to join COVID-19 vaccine production, Aurora Cannabis shares up after FQ2 revenue rides high on medical cannabis strength Life Science
Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial Life Science
Healthcare Roundup – Bristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancer; Merck antiviral molnupiravir effective in preventing COVID-19 in lung tissue Life Science
Healthcare Roundup – Bristol Myers Squibb’s Inrebic nabs European Commission approval; Pfizer/BioNTech double the vaccine supply to EU Life Science
Healthcare Roundup – Clover shares close up nearly 6% after Chamath Palihapitiya rebukes Hindenburg report; Bristol Myers Squibb wins FDA approval for lymphoma treatment Breyanzi Life Science
Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably Life Science
Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s Life Science
Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease Life Science
Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the market Life Science
